?

Michel Roberge
AbstractmPurpose: Hemiasterlin, hemiasterlin A and hemiasterlin B are newly isolated cytotoxic tripeptides with potential as antitumor drugs. We wished to determine their mechanism of cytotoxicity. Methods: We studied their effect on cell survival, cell cycle progression, and microtubule morphology in MCF-7 human mammary carcinoma cells. Results: At the nanomolar concentrations at which they were cytotoxic, the peptides induced arrest in mitotic metaphase. Hemiasterlin A produced abnormal mitotic spindles like those produced by the microtubule inhibitors taxol, nocodazole and vinblastine at low concentrations. At high concentrations hemiasterlin A did not cause microtubule bundling like taxol, but caused microtubule depolymerization like nocodazole and vinblastine.
Conclusions:
The hemiasterlins probably exert their cytotoxic effect by inhibiting spindle microtubule dynamics.
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The hemiasterlins are a family of potent cytotoxic peptides recently isolated from marine sponges [3, 15] . Hemiasterlin A is a tripeptide composed of the unusual amino acids trimethyltryptophan, tert-leucine and N-methyl homo vinylogous valine, and is closely related to hemiasterlin and hemiasterlin B (Fig. 1 ). This group of peptides is active in vitro against murine leukemia P388, human mammary carcinoma MCF-7, human glioblastoma/astrocytoma U373, human ovarian carcinoma HEY, and in vivo against P388 cells in mice [3] . The mechanism of cytotoxicity of this family of compounds is unknown. In this study we examined the effects of hemiasterlin A, hemiasterlin and hemiasterlin B on cell survival and cell cycle progression in human mammary carcinoma MCF-7 cells and suggest that they exert their cytotoxic effect by binding to tubulin and inhibiting spindle microtubule dynamics.
MCF-7 cells were grown as a monolayer at 37°C in a humidified atmosphere containing 10% CO2 in DMEM supplemented with 10% fetal calf serum, 100 U/ml penicillin and streptomycin, 2 mM L-glutamine, 1 mM sodium pyruvate, 1% MEM nonessential amino acids, 1 µg/ml bovine insulin, 1 µg/ml hydrocortisone, 1 ng/ml human EGF and 1 ng/ml β-estradiol. The hemiasterlins, geodiamolide B, taxol and nocodazole (Sigma) were dissolved in dimethyl sulfoxide (DMSO) and stored at -20°C. Vinblastine (David Bull Laboratories, Victoria, Australia) was used as a 1 mg/ml solution in physiological saline. Cytotoxicity was measured using a microculture tetrazolium assay [4] . MCF-7 cells were grown at low density in multiwell plates and treated with different concentrations of compounds for 20 h. The compounds were then washed away and the cells allowed to grow in normal medium for 3 -5 days before assay.
For mitotic arrest determination, MCF-7 cells were treated with different concentrations of compounds for 20 h, prepared for chromosome spreads using a previously described method [5] and the percentage of mitotic cells determined by fluorescence microscopy.
For tubulin immunofluorescence, MCF-7 cells were grown on poly-L-lysine-coated coverslips, treated with the compounds for 20 h, We first determined the cytotoxicity of the hemiasterlins towards MCF-7 human mammary carcinoma cells. Cells were treated for the duration of one cell cycle (20 h) with different concentrations of the compounds or the vehicle DMSO and cytotoxicity was determined after 3 -5 days using a microculture tetrazolium assay. DMSO had no effect. Hemiasterlin killed MCF-7 cells half-maximally at 0.5 nM, hemiasterlin A at 2 nM, and hemiasterlin B at 7 nM (Fig. 2) . Geodiamolide B, a cytotoxic cyclodepsipeptide also found in the marine sponge Cymbastela sp. [3] , was also tested and found to be less potent, killing cells halfmaximally at 80 nM. Since many antitumor drugs affect the transition between particular phases of the cell cycle, we next examined the effect of the hemiasterlins on mitosis. Cycling cells were treated with different concentrations of the hemiasterlins or DMSO for 20 h and the percentage of mitotic cells was determined microscopically. DMSO had no effect. All three hemiasterlins induced a concentration-dependent accumulation of cells in mitotic metaphase, with hemiasterlin having a half-maximal effect at 0.5 nM, hemiasterlin A at 2.5 nM, and hemiasterlin B at 28 nM (Fig. 3) . Since each compound caused mitotic arrest and cytotoxicity in the same concentration range, it is likely that mitotic arrest is an important determinant of their cytotoxic activity. Geodiamolide B, by contrast, failed to block cells in mitosis, even at 300 nM (Fig. 3) .
The most common compounds causing mitotic arrest are the microtubule inhibitors. We therefore compared the cytotoxic and antimitotic activity of the hemiasterlins with the activity of taxol, vinblastine and nocodazole, as representatives of the major classes of microtubule inhibitors. Taxol, vinblastine and nocodazole showed half-maximal cytotoxicity at 5 nM, 2 nM, and 63 nM (Fig. 2) and half-maximal ability to arrest cells in mitosis at 7 nM, 15 nM and 42 nM, respectively (Fig. 3) . The hemiasterlins are therefore potent compounds, with hemiasterlin and hemiasterlin A being more potent in both capacities than the microtubule inhibitors.
We next compared the morphology of cells treated with hemiasterlin A with those treated with the microtubule inhibitors. We treated cells with concentrations of Fig. 2 hemiasterlin A, taxol, vinblastine or nocodazole that produce half-maximal or maximal mitotic arrest and examined the morphology of their mitotic spindles by indirect immunofluorescence using a monoclonal antibody to β-tubulin and the distribution of their chromosomes using the fluorescent DNA dye bisbenzimide. The results are shown in Fig. 4 . In the presence of hemiasterlin A at 2 nM no completely normal spindles were seen. Some cells showed relatively minor abnormalities in which a bipolar spindle was present, but the astral microtubules were considerably longer than normal and the chromosomes were not completely confined to the metaphase plate. Most commonly cells had multiple asters, and the chromosomes were distributed in a spherical mass (Fig. 4 C, D) . Half-maximal concentrations of taxol, vinblastine and nocodazole produced the same types of abnormal spindle as hemiasterlin A (not shown). Hemiasterlin A at 10 nM, the lowest concentration causing maximal mitotic arrest in MCF-7 cells, caused microtubule depolymerization in mitotic cells (Fig. 4 E, F) . This was also the case for high concentrations of vinblastine and nocodazole (not shown). Taxol at high concentrations had a quite different effect, causing bundling of cytoplasmic microtubules in interphase cells and very dense multiple asters in mitotic cells.
The hemiasterlins are chemically novel tripeptides [3, 15] with promising potential for development as antitumor drugs. They show potent in vitro cytotoxicity against human solid tumor cell lines and show equally potent cytotoxicity against murine leukemia P388 both in vitro and in vivo [3] . Preliminary data indicate that the effective in vivo dose against P388 in mice is at least two orders of magnitude lower than the toxic dose (T. M. Allen, personal communication). In this study, we showed that at nanomolar concentrations these compounds are cytotoxic to MCF-7 cells, cause mitotic arrest, and at least one, hemiasterlin A, produces abnormal mitotic spindles. A broad array of drugs can arrest cells in mitosis, producing abnormal mitotic spindles. Some of these bind tubulin directly, such as the well-studied microtubule inhibitors taxol, vinblastine and nocodazole used here for comparative purposes [9, 10] . They do so at distinct sites, the taxol, vinca and colchicine domains respectively. At the low concentrations at which they cause mitotic arrest, all three produce abnormal spindles [9, 10] , as does hemiasterlin A. At higher concentrations each of the three drugs produces a different set of microtubule morphologies. Vinblastine and nocodazole depolymerize microtubules [9] , as does hemiasterlin A. At even higher concentrations vinblastine can assemble tubulin dimers into nearly crystalline arrays called vinblastine paracrystals [9] . In contrast, at high concentrations taxol enhances microtubule assembly and produces thick bundles of microtubules [10] . Hemiasterlin A at high concentrations does not produce paracrystals or microtubule bundles.
In recent years many other naturally occurring cytotoxic compounds have been isolated that bind tubulin, causing mitotic arrest. Their structures are extremely varied, including peptides such as phomopsin A and the dolastatins [7] , ustiloxin [12] , and cryptophycin [11] , as well as nonpeptide compounds such as maytansine, rhizoxin, halichondrin B, homohalichondrin B and the halistatins [7] , curacin A [2] , the spongistatins [1] , discodermolide [6] , steganacin, combrestatin, and podophyllotoxin [14] . In vitro these compounds bind in or near the taxol [6] , vinca [1, 7, 11, 12] , or colchicine domains [2, 14] , and are the subject of structure-activity studies. Their effects on microtubule morphology vary at high concentrations, as for taxol, vinblastine and nocodazole. However, what these diverse drugs appear to have in common, no matter where or how they bind to tubulin, is their ability, at the low concentrations at which they arrest cells in metaphase, to disrupt the delicate control of microtubule dynamics that is essential for the conversion of the interphase microtubule network into the precisely organized mitotic spindle and for the spindle to carry out its function of arranging and sorting chromosomes [9, 10] .
Other drugs that can arrest cells in mitosis are inhibitors of protein phosphatases 1 and 2 A [8, 13] . They also produce multiple asters with elongated microtubules [13, 16, 17] , but probably act indirectly on microtubules by promoting the phosphorylation of proteins such as microtubule-associated proteins that control microtubule dynamics. Hemiasterlin A does not inhibit protein phosphatases 1 or 2 A in vitro (C. Holmes, personal communication). Although the hemiasterlins could act indirectly on microtubules through another, unknown, mechanism, they are more likely to be microtubule inhibitors. In vitro binding studies should resolve this issue.
The hemiasterlins are small molecules with simpler structures than all known microtubule inhibitors, promising ease of chemical synthesis and structure-function studies. Cytotoxic drugs that cause metaphase arrest through disrupting microtubule dynamics are already valuable chemotherapeutic agents. It would be useful to identify new drugs of this type that act at lower concentrations, thereby reducing the possibility of pleiotropic and possibly deleterious effects, that are effective against multidrug-resistant tumor cells, and that can be produced cheaply. The hemiasterlins might fit these criteria.
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